Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_assertion type Assertion NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_head.
- NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_assertion description "[This observation suggests the possibility that PPARalpha and PPARgamma activators, or compounds that positively regulate PPAR gene expression, may represent novel NSAIDs for the topical or systemic treatment of common inflammatory skin diseases such as atopic dermatitis, psoriasis, and allergic contact dermatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_provenance.
- NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_assertion evidence source_evidence_literature NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_provenance.
- NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_assertion SIO_000772 18092840 NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_provenance.
- NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_assertion wasDerivedFrom befree-2016 NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_provenance.
- NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_assertion wasGeneratedBy ECO_0000203 NP646207.RAQjMmWYoTRa9mwlQ_TLs1mweVndkodfw_Rmaud9yiGD8130_provenance.